Latest Leadership News

Augustus Minerals has applied for a significant exploration licence in Papua New Guinea’s Vanapa River region, positioning itself within one of the world’s richest gold-copper belts while progressing its Mt Kare project.

Adavale Resources has uncovered significant resource growth potential at its London-Victoria gold deposit through historic data recovery and a new structural geology study, setting the stage for an imminent drilling campaign.

WhiteHawk Limited has launched its first Australian office in Perth and signed a Memorandum of Understanding with Novera to co-develop a cybersecurity and AI governance platform tailored for the Australian market and broader APEC region.

Starpharma’s 2025 AGM highlighted breakthrough partnerships and clinical progress, positioning the biotech for growth. Key deals with Genentech and Radiopharm Theranostics underpin a promising pipeline and expanding revenue streams.

Navigator Global Investments appoints Roger Davis as new Chair and suspends dividends to prioritize capital for growth and new partnerships.

Senetas Corporation Limited successfully passed all resolutions at its 2025 Annual General Meeting, including director re-elections, executive option grants, and a capital return proposal.

Wagners Holding Company Limited reported a strong FY25 with profits more than doubling, driven by robust construction demand in Southeast Queensland and growth in composite fibre technologies. The company raised $30 million to expand its concrete plants and composite production capacity, positioning for further growth in FY26.

Tamboran Resources has sanctioned its Shenandoah South Pilot Project, completed a record drilling campaign, and is progressing infrastructure to deliver gas to the Northern Territory by mid-2026. The company also announced a planned acquisition of Falcon Oil & Gas and raised $56 million in a public offering.

Tamawood Limited reports a modest profit increase for FY25 alongside the retirement of long-serving Chairman Robert Lynch. Early FY26 sales surge 39%, but a Work in Progress audit prompts a trading blackout.

Navigator Global Investments delivered record financial results in FY25, driven by strong revenue growth and strategic expansion, while suspending dividends to fuel future growth. Key leadership changes mark a new chapter for the alternative asset manager.

Island Pharmaceuticals will host a webinar to discuss the FDA's feedback on the clinical development and regulatory approval of its antiviral drug Galidesivir, including key considerations under the FDA's Animal Rule and Priority Review Voucher eligibility.

City Chic Collective has reversed its fortunes with a $15 million EBITDA turnaround in FY25, driven by strategic restructuring and strong ANZ growth. The company eyes a debt-free 2025 close and cash flow positivity in FY26 amid cautious optimism for US market expansion.